Delivery Order SPE2DB20D9759-SPE2DB25FD5MT
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,502.80 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials, with a performance period ending on July 31, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program. The IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,670.13 under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract, which has a ceiling value of $499,999,999 and is valid through November 2026. The contract is for the provision of 4567316735 ! YF-VAX 1 DOSE VIALS, a pharmaceutical product, to support the medical supply needs of military health facilities. As a key supplier in the federal...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the PEDVAXHIB vaccine in 0.5 mL vials. The delivery order has a potential value of $1,190.58 and a completion date of February 21, 2024. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued up to $4,999,999 through 2025, which allows the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $2,954.65 firm fixed-price delivery order contract is for the supply of a single pharmaceutical product, the YF-VAX 1 dose vial, with a period of performance through August 30, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $2,783.55 from the Defense Logistics Agency (DLA). The award is for the supply of 4567707314 YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $5,629.46. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the supply of PEDIARIX 0.5ML SYR 10S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of February 27, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB medical supply contract vehicle. The $2,817.45 award is for the delivery of YF-VAX 1 dose vials, with a period of performance through September 9, 2024. DMS Pharmaceutical Group is a key supplier of pharmaceuticals and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB program administered by the Defense Logistics Agency (DLA), a defense agency. The $13,917.75 firm fixed-price contract is for the provision of 4,567,789,152 units of the YF-VAX 1 dose vaccine, with a completion date of April 17, 2025. DMS Pharmaceutical Group is a key supplier of pharmaceutical products and medical supplies to the Department of Defense, holding a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical prime vendor program. The award, valued at $76,729.25, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of PEDVAXHIB VACCINE VIAL 0.5ML, valued at $1,593.36, with a performance period through March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency...